Replies to post #209333 on Biotech Values

[spongepaul]

Is there a probability that FMI will update their 2017 guidance in regards to recently receiving medicare payment for NSCLC? Does anyone think this development is substantial enough to move the needle? Disclosure: I'm still holding some shares that didn't get scooped up by Roche in the tender offer. TIA
-Paul